Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adnexal Diseases | 3 | 2024 | 106 | 1.020 |
Why?
|
Heart Rate, Fetal | 1 | 2024 | 75 | 0.910 |
Why?
|
Polyps | 1 | 2023 | 197 | 0.790 |
Why?
|
Electroporation | 3 | 2012 | 254 | 0.760 |
Why?
|
Magnetite Nanoparticles | 5 | 2017 | 315 | 0.730 |
Why?
|
Ovarian Neoplasms | 5 | 2024 | 4876 | 0.720 |
Why?
|
Cysts | 2 | 2023 | 681 | 0.720 |
Why?
|
Ovary | 3 | 2024 | 958 | 0.680 |
Why?
|
Pregnancy Trimester, First | 1 | 2024 | 908 | 0.680 |
Why?
|
Bile Duct Diseases | 1 | 2019 | 97 | 0.660 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2019 | 296 | 0.610 |
Why?
|
Hamartoma | 1 | 2019 | 235 | 0.580 |
Why?
|
Pancreatic Cyst | 1 | 2020 | 367 | 0.550 |
Why?
|
Endosonography | 1 | 2020 | 607 | 0.550 |
Why?
|
Ultrasonography | 5 | 2024 | 5952 | 0.540 |
Why?
|
Nipples | 1 | 2018 | 221 | 0.530 |
Why?
|
Ultrasonography, Prenatal | 1 | 2024 | 1745 | 0.520 |
Why?
|
Ultrasonography, Mammary | 1 | 2018 | 239 | 0.520 |
Why?
|
Endometriosis | 1 | 2023 | 874 | 0.500 |
Why?
|
Chemoembolization, Therapeutic | 2 | 2013 | 127 | 0.470 |
Why?
|
Hyperthermia, Induced | 3 | 2017 | 416 | 0.450 |
Why?
|
Gold | 2 | 2017 | 479 | 0.450 |
Why?
|
Liver | 6 | 2015 | 7502 | 0.420 |
Why?
|
Magnetic Resonance Imaging | 15 | 2024 | 36285 | 0.400 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2023 | 2292 | 0.390 |
Why?
|
Pancreatic Neoplasms | 4 | 2021 | 5349 | 0.390 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2018 | 936 | 0.360 |
Why?
|
Electrochemotherapy | 1 | 2010 | 7 | 0.360 |
Why?
|
Phototherapy | 1 | 2013 | 368 | 0.350 |
Why?
|
Neoplasms, Experimental | 2 | 2013 | 1228 | 0.350 |
Why?
|
Elasticity Imaging Techniques | 1 | 2015 | 388 | 0.350 |
Why?
|
Liver Cirrhosis | 3 | 2015 | 1930 | 0.330 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2010 | 189 | 0.320 |
Why?
|
Liver Neoplasms | 4 | 2023 | 4313 | 0.310 |
Why?
|
Catheterization | 1 | 2012 | 1426 | 0.270 |
Why?
|
Adenocarcinoma | 2 | 2021 | 6313 | 0.260 |
Why?
|
Cisplatin | 1 | 2012 | 1645 | 0.260 |
Why?
|
Image Enhancement | 3 | 2013 | 2880 | 0.250 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3211 | 0.220 |
Why?
|
Oxygen | 2 | 2011 | 4192 | 0.210 |
Why?
|
Mass Screening | 1 | 2018 | 5425 | 0.200 |
Why?
|
Neovascularization, Pathologic | 1 | 2011 | 2638 | 0.190 |
Why?
|
Extremities | 2 | 2023 | 865 | 0.180 |
Why?
|
Leiomyosarcoma | 1 | 2024 | 424 | 0.170 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3526 | 0.170 |
Why?
|
Embolization, Therapeutic | 3 | 2013 | 1407 | 0.160 |
Why?
|
Rats, Sprague-Dawley | 6 | 2013 | 8144 | 0.160 |
Why?
|
Leiomyoma | 1 | 2024 | 654 | 0.160 |
Why?
|
Shock | 1 | 2021 | 314 | 0.150 |
Why?
|
Diagnosis, Differential | 3 | 2024 | 12951 | 0.150 |
Why?
|
Rats | 10 | 2017 | 23681 | 0.150 |
Why?
|
Urogenital Abnormalities | 1 | 2021 | 256 | 0.150 |
Why?
|
Nanoconjugates | 1 | 2017 | 21 | 0.150 |
Why?
|
Contrast Media | 4 | 2023 | 5298 | 0.140 |
Why?
|
Retrospective Studies | 9 | 2024 | 80170 | 0.140 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2020 | 506 | 0.140 |
Why?
|
Cell Line, Tumor | 7 | 2017 | 16886 | 0.130 |
Why?
|
Observer Variation | 1 | 2022 | 2600 | 0.130 |
Why?
|
Diethylnitrosamine | 2 | 2013 | 45 | 0.130 |
Why?
|
Sensitivity and Specificity | 6 | 2023 | 14641 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 9273 | 0.120 |
Why?
|
Female | 13 | 2024 | 390316 | 0.120 |
Why?
|
Humans | 25 | 2024 | 758381 | 0.120 |
Why?
|
Uterine Neoplasms | 1 | 2024 | 1439 | 0.120 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 584 | 0.120 |
Why?
|
Incidental Findings | 1 | 2019 | 694 | 0.120 |
Why?
|
Gadolinium DTPA | 2 | 2023 | 823 | 0.110 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2024 | 3339 | 0.110 |
Why?
|
Infusions, Intra-Arterial | 1 | 2013 | 221 | 0.110 |
Why?
|
Pregnancy Outcome | 1 | 2024 | 2907 | 0.110 |
Why?
|
Ethiodized Oil | 1 | 2012 | 25 | 0.100 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2013 | 187 | 0.100 |
Why?
|
Area Under Curve | 1 | 2015 | 1632 | 0.090 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21017 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2821 | 0.090 |
Why?
|
Models, Animal | 3 | 2012 | 2112 | 0.090 |
Why?
|
Kidney Diseases | 1 | 2021 | 2083 | 0.090 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2013 | 638 | 0.090 |
Why?
|
Radiography | 2 | 2012 | 6955 | 0.090 |
Why?
|
Radiology | 1 | 2023 | 2102 | 0.080 |
Why?
|
Deoxycytidine | 1 | 2013 | 870 | 0.080 |
Why?
|
Photosensitizing Agents | 1 | 2013 | 618 | 0.080 |
Why?
|
Rabbits | 2 | 2013 | 4771 | 0.080 |
Why?
|
Drug Carriers | 1 | 2013 | 705 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20500 | 0.080 |
Why?
|
Antigens | 1 | 2014 | 1445 | 0.080 |
Why?
|
Reproducibility of Results | 4 | 2015 | 20052 | 0.080 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2010 | 345 | 0.070 |
Why?
|
Treatment Outcome | 6 | 2017 | 64379 | 0.070 |
Why?
|
Antigens, CD34 | 1 | 2010 | 653 | 0.070 |
Why?
|
Light | 1 | 2013 | 1345 | 0.070 |
Why?
|
Abdomen | 1 | 2013 | 1129 | 0.070 |
Why?
|
ROC Curve | 1 | 2015 | 3563 | 0.070 |
Why?
|
Risk Assessment | 3 | 2024 | 23883 | 0.070 |
Why?
|
Ablation Techniques | 1 | 2010 | 248 | 0.070 |
Why?
|
Hepatectomy | 1 | 2010 | 559 | 0.070 |
Why?
|
Doxorubicin | 1 | 2013 | 2209 | 0.070 |
Why?
|
Cell Survival | 2 | 2013 | 5781 | 0.070 |
Why?
|
Adult | 5 | 2024 | 219916 | 0.070 |
Why?
|
Animals | 13 | 2017 | 167777 | 0.070 |
Why?
|
Risk Factors | 2 | 2024 | 73806 | 0.070 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2013 | 0.070 |
Why?
|
Biopsy | 1 | 2018 | 6768 | 0.060 |
Why?
|
Male | 10 | 2021 | 358742 | 0.060 |
Why?
|
Rats, Wistar | 3 | 2017 | 1844 | 0.060 |
Why?
|
Killer Cells, Natural | 1 | 2015 | 2201 | 0.060 |
Why?
|
Carbon Dioxide | 1 | 2010 | 1146 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2850 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4312 | 0.060 |
Why?
|
Middle Aged | 5 | 2024 | 219560 | 0.060 |
Why?
|
Artifacts | 1 | 2013 | 1897 | 0.060 |
Why?
|
Prognosis | 1 | 2024 | 29558 | 0.050 |
Why?
|
Dendritic Cells | 1 | 2014 | 2723 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2023 | 15225 | 0.050 |
Why?
|
Surgery, Computer-Assisted | 1 | 2010 | 1008 | 0.050 |
Why?
|
Cell Movement | 1 | 2014 | 5201 | 0.050 |
Why?
|
Pregnancy | 1 | 2024 | 29742 | 0.050 |
Why?
|
Tumor Cells, Cultured | 1 | 2010 | 6127 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 3758 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2014 | 8946 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2024 | 58681 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39060 | 0.040 |
Why?
|
Palliative Care | 1 | 2013 | 3570 | 0.040 |
Why?
|
Young Adult | 2 | 2024 | 58808 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 6852 | 0.040 |
Why?
|
Apoptosis | 1 | 2013 | 9468 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2014 | 18125 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15785 | 0.040 |
Why?
|
Catheter Ablation | 1 | 2010 | 2740 | 0.030 |
Why?
|
United States | 2 | 2022 | 72140 | 0.030 |
Why?
|
Mucin-5B | 1 | 2017 | 147 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11070 | 0.030 |
Why?
|
Aged | 3 | 2024 | 168217 | 0.030 |
Why?
|
Nanocomposites | 1 | 2015 | 49 | 0.030 |
Why?
|
Protamines | 1 | 2015 | 112 | 0.030 |
Why?
|
Cell Tracking | 1 | 2015 | 138 | 0.030 |
Why?
|
Ferrosoferric Oxide | 1 | 2015 | 348 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2010 | 14481 | 0.030 |
Why?
|
Cellulose | 1 | 2013 | 118 | 0.030 |
Why?
|
Algorithms | 1 | 2013 | 13959 | 0.030 |
Why?
|
Dextrans | 1 | 2014 | 573 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2013 | 13591 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2012 | 6233 | 0.030 |
Why?
|
Angiography, Digital Subtraction | 1 | 2012 | 335 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2012 | 5199 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2013 | 2263 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2014 | 726 | 0.020 |
Why?
|
Hemorrhage | 1 | 2021 | 3400 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2012 | 944 | 0.020 |
Why?
|
Heparin | 1 | 2015 | 1632 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2646 | 0.020 |
Why?
|
Mice, Nude | 1 | 2013 | 3602 | 0.020 |
Why?
|
Movement | 1 | 2013 | 1474 | 0.020 |
Why?
|
Kidney | 1 | 2021 | 7016 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3574 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6209 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2012 | 2509 | 0.010 |
Why?
|
Vaccination | 1 | 2014 | 3356 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9160 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5861 | 0.010 |
Why?
|
Mice | 2 | 2014 | 81107 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 87888 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 13468 | 0.010 |
Why?
|
Concepts
(163)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_